Doug VanOort | Chairman and CEO |
Steve Jones | Executive Vice President |
George Cardoza | Senior Vice President and CFO |
Bill Bonello | Treasurer and Director, Corporate Development |
Rob Shovlin | President, Clinical Services Division |
Kathryn McKenzie | Vice President, Finance and Principal Accounting Officer |
Jessica King | Director, External Reporting |
Maher Albitar | Senior Vice President, Chief Medical Officer and Director, R&D |
James Rutherford | Stephens, Inc. |
Kevin Ellich | Craig-Hallum |
Nick Jansen | Raymond James |
Paul Knight | Janney Montgomery Scott |
Raymond Myers | The Benchmark Company |
Joe Munda | First Analysis |
Jeff Bernstein | Cowen |
Mathew Arens | First Light Asset Management |
Greetings, and welcome to NeoGenomics’ Fourth Quarter and Full Year 2017 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Doug VanOort, Chairman and Chief Executive Officer for NeoGenomics. Thank you, Mr. VanOort.